Page last updated: 2024-08-23

bisantrene and Leukemia, Myeloid, Acute

bisantrene has been researched along with Leukemia, Myeloid, Acute in 4 studies

*Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. [MeSH]

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Andersson, BS; Murray, D; Nieto, Y; Popat, U; Valdez, BC; Yuan, B1
Avigdor, A; Benjamini, O; Canaani, J; Danylesko, I; Dor, C; Lozinsky, K; Nagar, M; Nagler, A; Shemtov, N; Shimoni, A; Yerushalmi, R; Zlotnick, M1
Baruchel, A; Deméocq, F; Guillot, T; Leblanc, T; Lemerle, S; Leverger, G; Nelken, B; Schaison, G; Vannier, JP1
Aloespiriti, MA; Amadori, S; Avvisati, G; De Gregoris, C; Fazi, P; Latagliata, R; Mandelli, F; Petti, MC; Spadea, A1

Trials

1 trial(s) available for bisantrene and Leukemia, Myeloid, Acute

ArticleYear
A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia.
    European journal of haematology, 2021, Volume: 106, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anthracenes; Antibiotics, Antineoplastic; Biopsy; Bone Marrow; Disease Susceptibility; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Recurrence; Retreatment; Treatment Outcome; Young Adult

2021

Other Studies

3 other study(ies) available for bisantrene and Leukemia, Myeloid, Acute

ArticleYear
Enhanced cytotoxicity of bisantrene when combined with venetoclax, panobinostat, decitabine and olaparib in acute myeloid leukemia cells.
    Leukemia & lymphoma, 2022, Volume: 63, Issue:7

    Topics: Anthracenes; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Decitabine; Drug Synergism; Humans; Leukemia, Myeloid, Acute; Panobinostat; Phthalazines; Piperazines; Sulfonamides

2022
Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytine.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Follow-Up Studies; Heart Diseases; Hematologic Diseases; Humans; Infant; Kidney Diseases; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction

1994
Bisantrene in relapsed and refractory acute myelogenous leukemia.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:3

    Topics: Adult; Anthracenes; Antibiotics, Antineoplastic; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Recurrence

1993